# Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2

> **NCT02945228** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 449 (actual)

## Conditions studied

- Chronic Hepatitis C Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02945228
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-26
- **Primary completion:** 2019-07-26
- **Final completion:** 2019-07-26
- **Target enrollment:** 449 (ACTUAL)
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945228, "Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02945228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*